PL366289A1 - Novel synthesis and crystallization of piperazine ring-containing compounds - Google Patents

Novel synthesis and crystallization of piperazine ring-containing compounds

Info

Publication number
PL366289A1
PL366289A1 PL00366289A PL36628900A PL366289A1 PL 366289 A1 PL366289 A1 PL 366289A1 PL 00366289 A PL00366289 A PL 00366289A PL 36628900 A PL36628900 A PL 36628900A PL 366289 A1 PL366289 A1 PL 366289A1
Authority
PL
Poland
Prior art keywords
crystallization
containing compounds
piperazine ring
novel synthesis
synthesis
Prior art date
Application number
PL00366289A
Other languages
English (en)
Polish (pl)
Inventor
Claude Singer
Anita Liberman
Nina Finkelstein
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL366289A1 publication Critical patent/PL366289A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL00366289A 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds PL366289A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19

Publications (1)

Publication Number Publication Date
PL366289A1 true PL366289A1 (en) 2005-01-24

Family

ID=22442814

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00366289A PL366289A1 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds

Country Status (16)

Country Link
JP (1) JP2004500324A (tr)
KR (1) KR20020019902A (tr)
CN (4) CN1679586A (tr)
CA (1) CA2368815A1 (tr)
CZ (1) CZ20013658A3 (tr)
HK (1) HK1044116A1 (tr)
HR (1) HRP20010747A2 (tr)
HU (1) HUP0200839A3 (tr)
IL (1) IL146023A0 (tr)
PL (1) PL366289A1 (tr)
RU (1) RU2001128229A (tr)
SK (1) SK14672001A3 (tr)
TR (1) TR200103028T2 (tr)
WO (1) WO2000062782A1 (tr)
YU (1) YU74101A (tr)
ZA (1) ZA200108220B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038329A1 (fr) 1999-11-24 2001-05-31 Sumika Fine Chemicals Co., Ltd. Cristaux de mirtazapine anhydre et leur procede d'obtention
WO2001042239A1 (fr) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Procede de preparation d'un compose pyridinemethanol
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 ２−（４−メチル−２−フェニルピペラジン−１−イル）−３−シアノピリジンの製造方法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
CN108191873B (zh) * 2018-01-08 2021-09-24 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Also Published As

Publication number Publication date
WO2000062782A1 (en) 2000-10-26
YU74101A (sh) 2004-09-03
HRP20010747A2 (en) 2002-12-31
RU2001128229A (ru) 2003-07-10
IL146023A0 (en) 2002-07-25
HUP0200839A3 (en) 2003-05-28
CN1356903A (zh) 2002-07-03
TR200103028T2 (tr) 2002-01-21
SK14672001A3 (sk) 2002-11-06
KR20020019902A (ko) 2002-03-13
HUP0200839A2 (en) 2002-08-28
JP2004500324A (ja) 2004-01-08
CZ20013658A3 (cs) 2002-08-14
CN1680374A (zh) 2005-10-12
CA2368815A1 (en) 2000-10-26
CN1679586A (zh) 2005-10-12
CN1680365A (zh) 2005-10-12
ZA200108220B (en) 2006-02-26
HK1044116A1 (zh) 2002-10-11

Similar Documents

Publication Publication Date Title
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
CZ20011657A3 (cs) Nové piperazinové a piperidinové sloučeniny, způsob jejich přípravy a jejich pouľití
IL146023A0 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
PL346544A1 (en) Crystalline forms of eto2
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
NO20023072L (no) Syntese av krystallinske silikoaluminofosfater
IL140492A (en) Crystalline polymorph of ritonavir
HUP0204069A3 (en) Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
PL344581A1 (en) Chemical synthesis of morpholine derivatives
PL351395A1 (en) Novel synthesis of piperazine ring
GB9914253D0 (en) Synthesis of substitiuted amidines
HK1035535A1 (en) Crystalline forms of osanetant
EP1178805A4 (en) NOVEL SYNTHESIS AND CRYSTALLIZATION OF PIPERAZINE-CONTAINING COMPOUNDS
GB9909756D0 (en) Synthesis of polycarbonates
HUP0004755A3 (en) Polymorphic forms of crystalline roxifiban and pharmaceutical compositions containing them
GB0011407D0 (en) Synthesis of substituted prolines
AU1822500A (en) Synthesis of 4-ketocyclopentene and cyclopentadiene compounds
IL137918A0 (en) Solid support synthesis of 2-oxopiperazines
HU9904011D0 (en) Novel salts of dipeptid derivatives
AU4015900A (en) Synthesis of epoxy-thf compounds
PL336261A1 (en) Dissymmetrical synthesis of benzoxazinones through novel intermediate compounds
IL137917A0 (en) Solid phase synthesis of 1-aminohydantoins